TWO · Healthcare

Sunmax Biotechnology Co Ltd (4728)

Biotechnology

Sunmax Biotechnology Co Ltd (4728) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 4728

P/E ratio

25.00

Sunmax Biotechnology Co Ltd (4728) — FAQ

What is 4728's P/E ratio?

The price-to-earnings (P/E) ratio for Sunmax Biotechnology Co Ltd (4728) is 25.00 (data as of 2026-05-23).

Does Sunmax Biotechnology Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Sunmax Biotechnology Co Ltd (4728). Check the MyAverix Finance app for the latest dividend data.

What sector is Sunmax Biotechnology Co Ltd in?

Sunmax Biotechnology Co Ltd (4728) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 4728 listed on?

4728 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)